Have you seen our weekly newsletter with latest #HealthTech news?
Posted:
This week we have a brilliant and personal interview with a Biotech VC investor. In addition, we highlight the results of our VR twitter poll and opportunities to tackle inequalities in healthcare.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.